Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 18, 2014, Pages 4425-4441

  Paul, Michael ^a   Ippisch, Josef ^a   Herrmann, Christian ^a   Guber, Susanne ^a   Schultis, Wolfgang ^a  

^a SYNLAB ACADEMY   (Germany)

Author keywords

Cathinones; LC ESI MS QTOF; Metabolite identification; Stimulants; Targeted untargeted data acquisition

Indexed keywords

AMINES; BIOMOLECULES; BODY FLUIDS; INDUCTIVELY COUPLED PLASMA; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

CATHINONES; HIGH RESOLUTION MASS SPECTROMETRY; LC-ESI-MS-QTOF; LIMIT OF QUANTIFICATIONS; LIQUID-LIQUID EXTRACTION; METABOLITE IDENTIFICATION; PIPERAZINE DERIVATIVES; STIMULANTS;

MATRIX ALGEBRA;

1,3 BENZODIOXOLE DERIVATIVE; 3,4-METHYLENEDIOXYPYROVALERONE; ALKALOID; CATHINONE; DESIGNER DRUG; KETAMINE; METHYLPHENIDATE; PYRROLIDINE DERIVATIVE; RITALINIC ACID;

ALGORITHM; ANALOGS AND DERIVATIVES; DATA MINING; FACTUAL DATABASE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PROCEDURES; REPRODUCIBILITY; SUBSTANCE ABUSE; URINE;

ALGORITHMS; ALKALOIDS; BENZODIOXOLES; CHROMATOGRAPHY, LIQUID; DATA MINING; DATABASES, FACTUAL; DESIGNER DRUGS; HUMANS; KETAMINE; LIMIT OF DETECTION; LIQUID-LIQUID EXTRACTION; MASS SPECTROMETRY; METHYLPHENIDATE; PYRROLIDINES; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION;

EID: 84903776139     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7825-5     Document Type: Article

References (30)

1. Zuba D (2012) Identification of cathinones and other active components of 'legal highs' by mass spectrometric methods. Trends Anal Chem 32:15-30
2. Dresen S, Ferreiros N, Putz M, Westphal F, Zimmermann R, Auwarter V (2010) Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 45(10):1186-1194. doi: 10.1002/jms.1811
3. Katagi M, Kamata T, Zaitsu K, Shima N, Kamata H, Nakanishi K, Nishioka H, Miki A, Tsuchihashi H (2010) Metabolism and toxicologic analysis of tryptamine-derived drugs of abuse. Ther Drug Monit 32(3):328-331. doi: 10.1097/FTD.0b013e3181dcb40c
4. Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168(2):458-470. doi: 10.1111/j.1476-5381. 2012.02145.x
5. Shulgin A (1991) PiHKAL - a chemical love story. Transform Press, Berkeley, California
6. Shulgin A (1997) TiHKAL - the continuation. Transform Press, Berkeley, California
7. Zaitsu K, Katagi M, Kamata H, Nakanishi K, Shima N, Kamata T, Nishioka H, Miki A, Tatsuno M, Tsuchihashi H (2010) Simultaneous analysis of six novel hallucinogenic (tetrahydobenzodifuranyl)aminoalkanes (FLYs) and (benzodifuranyl)aminoalkanes (DragonFLYs) by GC-MS, LC-MS and LC-MS-MS. Forensic Toxicol 28:9-18
8. Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2013) Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-alpha-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products. Forensic Toxicol online first: 3rd June 2013
9. Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2013) Two new synthetic cannabinoids, AM 2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivative, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and C-N-NBOMe, identified in illegal products. Forensic Toxicol online first: 5th November 2013
10. Dresen S, Ferreiros N, Gnann H, Zimmermann R, Weinmann W (2010) Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem 396(7):2425-2434. doi: 10.1007/s00216-010-3485-2
11. Dresen S, Gergov M, Politi L, Halter C, Weinmann W (2009) ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology. Anal Bioanal Chem 395(8):2521-2526. doi: 10.1007/s00216-009-3084-2
12. Maurer HH, Pfleger K, Weber A (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites, vol 4th Edition edn. Wiley-VCH, Weinheim, Germany
13. Roesner P, Junge T, Westphal F, Fritschi G (2013) Mass spectra of designer drugs 2014. Wiley-VCH, Weinheim, Germany
14. Concheiro M, Anizan S, Ellefsen K, Huestis MA (2013) Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem 405(29):9437-9448. doi: 10.1007/s00216-013-7386-z
15. Broecker S, Herre S, Wust B, Zweigenbaum J, Pragst F (2011) Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 400(1):101-117. doi: 10.1007/s00216-010-4450-9
16. Sundstrom M, Pelander A, Angerer V, Hutter M, Kneisel S, Ojanpera I (2013) A high-sensitivity ultra-high performance liquid chromatography/high- resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine. Anal Bioanal Chem 405(26):8463-8474. doi: 10.1007/s00216-013-7272-8
17. Yanes EG, Lovett DP (2012) High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. J Chromatogr B: Analyt Technol Biomed Life Sci 909:42-50. doi: 10.1016/j.jchromb.2012.10.013
18. Peters FT (2007) Stability of analytes in biosamples - an important issue in clinical and forensic toxicology? Anal Bioanal Chem 388(7):1505-1519. doi: 10.1007/s00216-007-1267-2
19. Tsujikawa K, Mikuma T, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H (2012) Degradation pathways of 4-methylmethcathinone in alkaline solution and stability of methcathinone analogs in various pH solutions. Forensic Sci Int 220(1-3):103-110. doi: 10.1016/j.forsciint.2012.02.005
20. Sorensen LK (2011) Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J Chromatogr B: Analyt Technol Biomed Life Sci 879(11-12):727-736. doi: 10.1016/j.jchromb.2011.02.010
21. Johnson RD, Botch-Jones SR (2013) The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions. J Anal Toxicol 37(2):51-55. doi: 10.1093/jat/bks138
22. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A (2000) Bioanalytical method validation - a revisit with a decade of progress. Pharm Res 17(12):1551-1557
23. Peters FT, Hartung M, Herbold M, Schmitt G, Daldrup T, Musshoff F (2009) Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen Anforderungen an die Validierung von Analysenmethoden. ToxichemKrimtech 76(3):185-208
24. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75(13):3019-3030
25. Baselt RC (2011) Disposition of toxic drugs and chemicals in man, 9th edn. Biomedical Publications, Seal Beach, California
26. Wang KC, Shih TS, Cheng SG (2005) Use of SPE and LC/TIS/MS/MS for rapid detection and quantitation of ketamine and its metabolite, norketamine, in urine. Forensic Sci Int 147(1):81-88. doi: 10.1016/j.forsciint.2004.03.031
27. Bijlsma L, Sancho JV, Hernandez F, Niessen WM (2011) Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra. J Mass Spectrom 46(9):865-875. doi: 10.1002/jms.1963
28. Niessen WM (2011) Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry. Mass Spectrom Rev 30(4):626-663. doi: 10.1002/mas.20332
29. Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 45(12):1426-1442. doi: 10.1002/jms.1859
30. Strano-Rossi S, Cadwallader AB, de la Torre X, Botre F (2010) Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 24(18):2706-2714. doi: 10.1002/rcm.4692